Replies to post #772280 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

None of those are parameters for a rigorous trials. It’s all hearsay at this point. If Direct really did work the way they’re trying to spin it, then management should all be fired.

[Galzus Research]

So, some 40 patients defied death and entered an unproven trial on a glimmer of hope. Three died before the treatment had time to work.

This (a small group of patients having a Lazarus effect or some other unusually outstanding benefit) happens in almost every phase 1 trial. It's one reason JANX is so hyped right now.

Learningcurve has the right of it. If NWBO management had as much confidence in DCVax-Direct as the longs on this board, they would have moved it forward (into a registrational trial) starting almost 10 years ago.

There is no strategic explanation to just keep going with the status quo while you're able to raise funds against a billion-dollar market cap for years and years. The simplest explanation is that NWBO management sees these phase 1 data for what they are: a neat signal of something promising.

[manibiotech]

It maybe news to you that Ph 1 is not designed or meant for efficacy and you can not claim efficacy based on Ph 1 trial . It is a well established fact.